Lv3
260 积分 2022-12-09 加入
Disitamab vedotin plus toripalimab in patients with locally advanced or metastatic urothelial carcinoma (RC48-C014): a phase 1b/2 dose-escalation and dose-expansion study
1个月前
已完结
MTHFD2 Enhances cMYC O-GlcNAcylation to Promote Sunitinib Resistance in Renal Cell Carcinoma
1个月前
已完结
Targeting the Metabolic Enzyme PGAM2 Overcomes Enzalutamide Resistance in Castration-Resistant Prostate Cancer by Inhibiting BCL2 Signaling
2个月前
已完结
m6A modification promotes EMT and metastasis of castration-resistant prostate cancer by upregulating NFIB
6个月前
已完结
Novel insights into causal effects of serum lipids and lipid-modifying targets on cholelithiasis
9个月前
已完结
m6A modification promotes EMT and metastasis of castration-resistant prostate cancer by upregulating NFIB
10个月前
已完结
非转移性去势抵抗性前列腺癌的治疗进展
10个月前
已完结
Decreased E-cadherin expression is associated with poor prognosis in patients with prostate cancer
1年前
已完结
Exploring the cross-cancer effect of circulating proteins and discovering potential intervention targets for 13 site-specific cancers
1年前
已完结
皖公网安备34019202002308
